OTCPK:VMCS

Stock Analysis Report

VisualMED Clinical Solutions

Executive Summary

VisualMED Clinical Solutions Corp., a medical information company, distributes clinical information systems.


Snowflake Analysis

Excellent balance sheet with weak fundamentals.

Share Price & News

How has VisualMED Clinical Solutions's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: VMCS's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

0%

VMCS

4.9%

US Healthcare Services

9.4%

US Market


1 Year Return

-91.5%

VMCS

15.5%

US Healthcare Services

-6.8%

US Market

Return vs Industry: VMCS underperformed the US Healthcare Services industry which returned 13.5% over the past year.

Return vs Market: VMCS underperformed the US Market which returned -10% over the past year.


Shareholder returns

VMCSIndustryMarket
7 Day0%4.9%9.4%
30 Day-33.3%0.9%-3.9%
90 Day-44.0%-0.06%-16.5%
1 Year-91.5%-91.5%15.9%15.5%-4.8%-6.8%
3 Year16.7%16.7%71.2%70.3%23.4%15.2%
5 Year-30.0%-30.0%51.3%49.9%41.3%25.7%

Price Volatility Vs. Market

How volatile is VisualMED Clinical Solutions's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is VisualMED Clinical Solutions undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether VisualMED Clinical Solutions is trading at an attractive price based on the cash flow it is expected to produce in the future. But as VisualMED Clinical Solutions has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Examine VisualMED Clinical Solutions's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through VisualMED Clinical Solutions regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is VisualMED Clinical Solutions forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

25.2%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as VisualMED Clinical Solutions has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has VisualMED Clinical Solutions performed over the past 5 years?

20.6%

Historical Healthcare annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, VisualMED Clinical Solutions has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

Financial Health

How is VisualMED Clinical Solutions's financial position?


In this section we usually analyse VisualMED Clinical Solutions's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. VisualMED Clinical Solutions has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of VMCS’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when VisualMED Clinical Solutions's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is VisualMED Clinical Solutions's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate VMCS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate VMCS's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if VMCS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if VMCS's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of VMCS's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

14.8yrs

Average board tenure


CEO

VisualMED Clinical Solutions has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
André Nadeau
Member of Advisory Board14.83yrsno datano data
Christian Chagnon
Member of Advisory Board14.83yrsno datano data
Gerard Dab
Co-Founder & Chairman15.5yrsno datano data
Louis Lombardo
Director15.5yrsno datano data
Jean-Lucien Rouleau
Member of Advisory Board14.83yrsno datano data
Todd McConnell
Member of Advisory Board14.83yrsno datano data

14.8yrs

Average Tenure

71yo

Average Age

Experienced Board: VMCS's board of directors are seasoned and experienced ( 14.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Insufficient data to determine if shareholders have been diluted in the past year.


Top Shareholders

Company Information

VisualMED Clinical Solutions Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: VisualMED Clinical Solutions Corp.
  • Ticker: VMCS
  • Exchange: OTCPK
  • Founded: 1999
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$313.838k
  • Shares outstanding: 224.17m
  • Website: https://null

Number of Employees


Location

  • VisualMED Clinical Solutions Corp.
  • 50 West Liberty Street
  • Suite 880
  • Reno
  • Nevada
  • 89501
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
VMCSOTCPK (Pink Sheets LLC)YesCommon StockUSUSDOct 2004

Biography

VisualMED Clinical Solutions Corp., a medical information company, distributes clinical information systems. The company provides VisualMED system, a suite of software modules that constitute a functional Clinical Information System. VisualMED is an informatics tool that enables the physician to make informed diagnostic and therapeutic decisions at the point of care. It also offers VisualMED modules, including administrative/support module that allows users with the appropriate security rights to access screens that are used to define and modify the basic architectural structure; VisualMED nursing module, which integrates all physician/nursing clinical functions at the order entry and clinical data entry levels; and VisualMED clinical module that correspond to the individual clinical specialty of medicine of the healthcare institution or a particular division or ward of the institution, such as VisualER, VisualSurgeon, VisualPediatrics, and VisualICU. In addition, the company provides electronic medical record modules, which are used by physicians, consultants, nursing staff, and paramedical staff to record patient’s admission and progress notes; and VisualONCOLOGY module to oncology departments and cancer clinics. It serves hospitals, healthcare delivery organizations, and regional and national healthcare authorities. The company was formerly known as Ancona Mining Corp. and changed its name to VisualMED Clinical Solutions Corp. in November 2004. VisualMED Clinical Solutions Corp. was founded in 1999 and is based in Reno, Nevada. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/04/09 02:33
End of Day Share Price2020/04/02 00:00
Earnings2013/12/31
Annual Earnings2013/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.